Community Research and Development Information Service - CORDIS

Results 1 - 10 of 326
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
King of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies
ID: 306029
Start date: 2013-04-01, End date: 2017-03-31
Extensive clinical and epidemiological data clearly shows that chronic periodontal disease (PD), the most prevalent infectious inflammatory disease of mankind, is strongly linked to systemic inflammatory diseases such as cardiovascular diseases (CVD) , rheumatoid arthritis (R...
Programme: FP7-HEALTH
Record Number: 106057
Last updated on: 2017-10-06
Human stem cell applications for the treatment of hearing loss
ID: 603029
Start date: 2013-11-01, End date: 2017-10-31
Hearing impairment is the most frequent human sensory deficit and is mainly caused by the irreversible loss of neurosensory cells in the cochlea. The lack of human otic cell models represents a significant roadblock that has hampered the development of drug-based or cell-base...
Programme: FP7-HEALTH
Record Number: 110640
Last updated on: 2017-09-24
Neurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing
ID: 602407
Start date: 2013-09-01, End date: 2018-02-28
Conduct Disorder (CD) and Oppositional Defiant Disorder with symptoms of Conduct Disorder (which is included among the abbreviation “CD” throughout the proposal) has a highly negative impact for the affected individual as well as for families and society. Although the number ...
Programme: FP7-HEALTH
Record Number: 110199
Last updated on: 2017-09-24
Towards Early diagnosis and biomarker validation in Arthritis Management
ID: 305549
Start date: 2012-11-01, End date: 2016-10-31
An ideal intervention in a chronic inflammatory disease such as Rheumatoid Arthritis (RA) would be a preventive one. In order to develop preventive strategies and therapies two key developments need to occur: (1) Biomarkers need to be identified that can be used to predict an...
Programme: FP7-HEALTH
Record Number: 105516
Last updated on: 2017-09-10
A European Platform for Translational Cancer Research
ID: 260791
Start date: 2011-01-01, End date: 2016-12-31
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer r...
Programme: FP7-HEALTH
Record Number: 97701
Last updated on: 2017-09-10
Fast Automated Multiplex Analysis of Neonatal Sepsis Markers on a Centrifugal Microfluidic Platform
ID: 258759
Start date: 2011-01-01, End date: 2014-06-30
The global frequency of neonatal sepsis is 1-21 newborns per 1000 live births with mortality rates as high as 35-70%, amounting to 100,000s of annual cases. The consortium has identified a real and pressing need for increasing diagnostic efficacy in a setting that imposes a d...
Programme: FP7-HEALTH
Record Number: 97617
Last updated on: 2017-09-10
Prevention of Hospital Infections by Intervention and Training
ID: 241928
Start date: 2010-01-01, End date: 2014-06-30
The aim of PROHIBIT is to understand existing guidelines and practices to prevent healthcare associated infections (HAI) in European hospitals, identify factors that enable and prevent compliance with best practices, and test the effectiveness of interventions of known effica...
Programme: FP7-HEALTH
Record Number: 93826
Last updated on: 2017-09-10
Lipid droplets as dynamic organelles of fat deposition and release: Translational research towards human disease
ID: 202272
Start date: 2008-05-01, End date: 2012-10-31
Lipids are central to the regulation and control of cellular processes by acting as basic building units for biomembranes, the platforms for the vast majority of cellular functions. Recent developments in lipid mass spectrometry have set the scene for a completely new way to ...
Programme: FP7-HEALTH
Record Number: 88230
Last updated on: 2017-09-10
International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research
ID: 278514
Start date: 2011-10-01, End date: 2017-09-30
Though survival of children with acute lymphoblastic leukaemia (ALL) has improved, relapse remains a leading cause of mortality in childhood cancer. Given the rarity of the disease, only a large international cooperative group can recruit sufficient patients for prospective s...
Programme: FP7-HEALTH
Record Number: 102104
Last updated on: 2017-09-03
Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock
ID: 602202
Start date: 2013-09-01, End date: 2018-08-31
Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) represents a major European health care concern with mortality rates between 40-70%. Approximately 70-80% of these patients present with multivessel disease defined as coronary lesions in more than one vess...
Programme: FP7-HEALTH
Record Number: 110170
Last updated on: 2017-08-27
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-10-21
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top